JM
Jacob Ma-Weaver
10% Owner

Jacob Ma-Weaver insider trades: MEI Pharma (MEIP) stock purchases

10% Owner, MEI Pharma Last trade Sep 22, 2023 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2022
2
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jacob reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 22, 2023MEIP↑ Buy$220K
Sep 21, 2023MEIP↑ Buy$625K
May 25, 2022ABIO↑ Buy$197K
May 19, 2022ABIO↑ Buy$30K
May 16, 2022ABIO↑ Buy$194K
May 11, 2022ABIO↑ Buy$104K
May 9, 2022ABIO↑ Buy$283K
May 2, 2022ABIO↑ Buy$78K
Apr 25, 2022ABIO↑ Buy$32K
Apr 18, 2022ABIO↑ Buy$21K
Apr 14, 2022ABIO↑ Buy$41K
Apr 12, 2022ABIO↑ Buy$243K
Apr 7, 2022ABIO↑ Buy$240K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jacob Ma-Weaver's insider trades

Jacob Ma-Weaver is a 10% owner of MEI Pharma (MEIP). Since Apr 7, 2022, Jacob has reported 13 open-market purchases worth $2.3M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (6 filings), grants and awards (3 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MEIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.